60% of high-priority research goes unfunded.
Select the text below and copy the link.
Thank you. Your email has been registered
Dr Réjean Lapointe is developing a gel to improve immunotherapy.
The latest Canadian Cancer Statistics report shows about half of Canadians are expected to be diagnosed with cancer in their lifetime.
Monday to Friday